July 21, 2009
Gerhard Symons asks Dr Carlos de Sousa, Vice President Licensing at Nycomed (Zurich) about the firm's in-licensing activities, and what differentiates it from its mid-tier and Big Pharma competitors.
|
March 31, 2009
By:
Gerhard Symons
Gerhard Symons realises that just one simple question can expose complex tensions between short-term profit motive, long-term market building and perception management of the industry.
|
March 3, 2009
By:
Gerhard Symons
This month, the Royal College of Physicians wil recommend a 'new covenant' between industry, clinicians and patients. The ABPI's Dr Richard Tiner, a working party member on the report, tells Gerhard Symons why transparency is key.
|
January 27, 2009
By:
Gerhard Symons
Industry is working more innovatively with academia on 'front-end' drug discovery. Gerhard Symons asks what this entails, and what are the challenges and rewards of this nascent paradigm?
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
